Back to top

Image: Bigstock

Arbutus' Shares March Higher, Can It Continue?

Read MoreHide Full Article

As of late, it has definitely been a great time to be an investor in Arbutus Biopharma Corporation (ABUS - Free Report) . The stock has moved higher by 53.3% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could suggest that the stock may be on the right path.

We certainly think that this might be the case, particularly if you consider ABUS’ recent earnings estimate revision activity. From this look, the company’s future is quite favorable; as ABUS has earned itself a Zacks Rank #1 (Strong Buy), meaning that its recent run may continue for a bit longer, and that this isn’t the top for the in-focus company. You can see the complete list of today’s Zacks #1 Rank stocks here.

Zacks Top 10 Stocks for 2020

In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-hold tickers for the entirety of 2020?

Last year's 2019 Zacks Top 10 Stocks portfolio returned gains as high as +102.7%. Now a brand-new portfolio has been handpicked from over 4,000 companies covered by the Zacks Rank. Don’t miss your chance to get in on these long-term buys.

Access Zacks Top 10 Stocks for 2020 today >>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Arbutus Biopharma Corporation (ABUS) - free report >>

Published in